The role of calcium metabolism assessment in the clinical setting of interstitial lung diseases

P. Cameli (Siena (SI), Italy), C. Caffarelli (Siena (SI), Italy), M. D'Alessandro (Siena (SI), Italy), L. Bergantini (Siena (SI), Italy), M. Armati (Siena (SI), Italy), M. Tomai Pitinca (Siena (SI), Italy), P. Sestini (Siena (SI), Italy), S. Gonnelli (Siena (SI), Italy), E. Bargagli (Siena (SI), Italy)

Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis
Session: Moving forward in various aspects of sarcoidosis
Session type: E-poster
Number: 706

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Cameli (Siena (SI), Italy), C. Caffarelli (Siena (SI), Italy), M. D'Alessandro (Siena (SI), Italy), L. Bergantini (Siena (SI), Italy), M. Armati (Siena (SI), Italy), M. Tomai Pitinca (Siena (SI), Italy), P. Sestini (Siena (SI), Italy), S. Gonnelli (Siena (SI), Italy), E. Bargagli (Siena (SI), Italy). The role of calcium metabolism assessment in the clinical setting of interstitial lung diseases. 706

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of lung biopsies in the diagnosis of interstitial lung diseases in a clinical real-life setting
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


The effectiveness of pulmonary rehabilitation in interstitial lung diseases in terms of functional markers
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018

The role of macrophages in interstitial lung diseases
Source: Eur Respir Rev, 26 (145) 170009; 10.1183/16000617.0009-2017
Year: 2017



Identifying pulmonary hypertension in newly recognized interstitial lung diseases – a role of new scoring system
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020


Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis
Source: Eur Respir Rev 2012; 21: 48-56
Year: 2012



Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure
Source: Eur Respir Rev, 30 (162) 210077; 10.1183/16000617.0077-2021
Year: 2021



Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma
Source: Eur Respir J, 55 (4) 1901340; 10.1183/13993003.01340-2019
Year: 2020



Pivotal role of the HMGB1/sRAGE axis in drug-induced lung injury in advanced lung cancer with pre-existing interstitial lung disease
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020


Linking clinical phenotypes of chronic lung allograft dysfunction to changes in lung structure
Source: Eur Respir J 2015; 46: 1430-1439
Year: 2015



COPD as a lung disease with heterogeneous systemic inflammatory consequences: clinical impact
Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD
Year: 2011


Role of the inflammasome in the pathophysiology of antisynthetase-associated interstitial lung disease.
Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Year: 2021

A potential role for sildenafil in the management of pulmonary hypertension associated with parenchymal lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 425s
Year: 2006

Frequency and impact of interstitial lung disease on clinical state and mortality in systemic scleroderma
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012

Clinical management implications of histologic information provided by lung biopsy in the multidisciplinary evaluation of interstitial lung diseases.
Source: Virtual Congress 2020 – The hot and cold of interventional pulmonology
Year: 2020




Quantitative assessment of lung pathology in interstitial lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 243s
Year: 2001

Hepatic function markers in COPD as a systemic implication of the disease
Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates
Year: 2008

The role of biomarkers in management of interstitial lung disease: implications of biomarkers derived from type II pneumocytes
Source: Eur Respir Mon; 2009: 46: 47–66
Year: 2009

Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression?
Source: Eur Respir J , 49 (2) 1602345; DOI: 10.1183/13993003.02345-2016
Year: 2017